Additionally, the PI3K–Akt signaling pathway, proteoglycans in cancer, chemical carcinogenesis—receptor activation, and Alzheimer's disease pathways were also notably enriched. This evidence concerns the gene AKT1 and early-onset autosomal dominant Alzheimer disease.